RxDoctor Payments Data

Eric Anklin, OD

Optometrist · Tecumseh, MINPI 1861580169

Payments from drug & device makers

$2,953in general payments, 2019–2025

Across 45 payments — averaging $65.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
  • Alcon$240
  • Bausch & Lomb Americas Inc.$157
  • Oyster Point Pharma, Inc.$121
  • Optos, Inc.$111
  • Johnson & Johnson Vision Care, Inc.$99
  • plus $86 from 4 others

What the payments were for

  • Travel & lodging$1,80761%
  • Food & beverage$1,08237%
  • Gifts$191%
  • Entertainment$452%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,953 in reported general payments places this provider in the 90th percentile of 1,523 optometrist providers in Michigan.

See all optometrist providers in Michigan

Medicare billing

Part B allowed, 2024
$34,502
Medicare patients
223
Services billed
336

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclosporine20$11,075
LumiganBimatoprost15$5,745
Latanoprost165$1,918
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha39$674
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat21$347
ValacyclovirValacyclovir Hcl12$305
Timolol Maleate42$297
Prednisolone Acetate11$293

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLumigan$22$5,74515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,523 optometrist providers in Michigan.

Other optometrist in Tecumseh

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →